Get App
Download App Scanner
Scan to Download
Advertisement

Nephrocare Health Services IPO Subscribed 12% On Day One; Check GMP

Nephrocare Health Services IPO Subscribed 12% On Day One; Check GMP
(Image source: Linkedin/Nephrocare Health Services)

Nephrocare Health Services Ltd.'s initial public offer was subscribed 12% on the launch day on Wednesday.

The IPO is a book-building issue worth Rs 871.05 crore. The IPO is a combination of fresh issue of 77 lakh shares, worth Rs 353.4 crore and an offer-for-sale (OFS) of 1.13 crore shares, aggregating to Rs 517.64 crore. 

The Nephrocare Health IPO price band has been set between Rs 438 and Rs 460 per share. The IPO lot size consists of 32 shares. The retail investors need to apply for at least a single lot size, amounting to a minimum investment of Rs 14,720 based on the upper price band per application.

Incorporated in 2010, Nephrocare Health Services provides end-to-end dialysis care through a wide network of clinics across India and select international markets. The company offers services including diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy.

The company will use Rs 136 crore from the fresh issue to repay debt and Rs 129 crore for capital expenditure for opening new dialysis clinics in India.

The share allotment status is expected to be finalised on Dec. 15. Nephrocare Health Services will list on the BSE and NSE on Dec. 17.

ICICI Securities is the book-running lead manager and Kfin Technologies Ltd. is the registrar of the issue.

Nephrocare Subscription Details

The Nephrocare Health Services IPO was subscribed 12% as of 5:00 p.m. on Wednesday.

  • Qualified Institutional Buyers (QIBs): Nil

  • Non-Institutional Investors (NIIS): 9%

  • Retail Individual Investors: 23%

  • Employee Reserved: 53%

Nephrocare IPO GMP

Nephrocare Health Services Ltd.'s grey market premium is at nil on Wednesday, according to Investorsgain website. The GMP indicates a listing price of Rs 460 apiece, which means upon listing, Nephrocare may offer no additional gain to investors.

Note: GMP does not represent official data and is based on speculation.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search